ED
The startup operates a screening test facility that detects a unique altered carbohydrate produced exclusively by cancer and precancerous cells in the mucus lining. This technology enables healthcare institutions to identify cancer at its earliest stages, significantly improving patient survival rates.
Updated 3 months ago
Funding
$360K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup operates a screening test facility that detects a unique altered carbohydrate produced exclusively by cancer and precancerous cells in the mucus lining. This technology enables healthcare institutions to identify cancer at its earliest stages, significantly improving patient survival rates.